Investors Home

Webcast ImageWebcast
Q2 2014 PharMerica Corporation Earnings Conference Call (Live)
08/05/14 at 10:00 a.m. ET
Corporate Profile
PharMerica Corporation is pharmacy management services provider dedicated to providing quality customer service and innovative pharmacy solutions to customers and patients in long-term care settings and in the home. PharMerica is a public company formed through the combination of the institutional pharmacy business of national healthcare services company Kindred Healthcare Inc. and pharmaceutical services company AmerisourceBergen. As a result of this combination effective August 1, 2007, PharMerica ranks as an industry-leading U.S. provider of pharmacy management services in terms of annual revenues. Headquartered in Louisville, Kentucky, PharMerica operates approximately 103 institutional and specialty infusion pharmacies in 45 states that serve over 300,000 licensed beds for patients of long-term care facilities. PharMerica fills approximately 40 million prescriptions annually. PharMerica has approximately 6,000 employees nationwide.
PMC (Common Stock)
ExchangeNYSE (US Dollar)
Price$27.25
Change (%) Stock is Up 0.25 (0.93%)
Volume74,229
Data as of 07/30/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
07/14/14PharMerica Corporation Announces Second Quarter 2014 Earnings Call and WebcastPrinter Friendly Version
07/01/14Amerita, a Subsidiary of PharMerica, Expands into Arizona Through the Acquisition of Altius HealthcarePrinter Friendly Version
05/09/14PharMerica to Present at the Bank of America Merrill Lynch 2014 Health Care ConferencePrinter Friendly Version
05/01/14PharMerica Reports First Quarter 2014 ResultsPrinter Friendly Version
Upcoming EventsMore >>
DateTitle
08/05/14 10:00 a.m. ET
Q2 2014 PharMerica Corporation Earnings Conference Call

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.